Reaction Details Report a problem with these data
Target
Putative hydrolase
Ligand
BDBM18862
Substrate
n/a
Meas. Tech.
Biochemical Characterization of Cif Inhibitors
IC50
4700±600 nM
Citation
 Madden, DR; Bahl, CD; Hammock, BD; Morisseau, C Compounds and methods for inhibiting Cif virulence factor US Patent  US10322118 Publication Date 6/18/2019 
Target
Name:
Putative hydrolase
Synonyms:
CFTR inhibitory factor, Cif | Putative hydrolase | cif
Type:
Enzyme Catalytic Domain
Mol. Mass.:
35786.52
Organism:
Pseudomonas aeruginosa (strain UCBPP-PA14)
Description:
A0A0H2ZD27
Residue:
319
Sequence:
MILDRLCRGLLAGIALTFSLGGFAAEEFPVPNGFESAYREVDGVKLHYVKGGQGPLVMLVHGFGQTWYEWHQLMPELAKRFTVIAPDLPGLGQSEPPKTGYSGEQVAVYLHKLARQFSPDRPFDLVAHDIGIWNTYPMVVKNQADIARLVYMEAPIPDARIYRFPAFTAQGESLVWHFSFFAADDRLAETLIAGKERFFLEHFIKSHASNTEVFSERLLDLYARSYAKPHSLNASFEYYRALNESVRQNAELAKTRLQMPTMTLAGGGHGGMGTFQLEQMKAYAEDVEGHVLPGCGHWLPEECAAPMNRLVIDFLSRGR
  
Inhibitor
Name:
BDBM18862
Synonyms:
2-[4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl]acetic acid | CHEMBL41632 | TRIAC | Tiratricol | Triiodothyroacetic acid, 3 | US10322118, Entry Tiratricol
Type:
Small organic molecule
Emp. Form.:
C14H9I3O4
Mol. Mass.:
621.9323
SMILES:
OC(=O)Cc1cc(I)c(Oc2ccc(O)c(I)c2)c(I)c1
Structure:
Search PDB for entries with ligand similarity: